Follicular Lymphoma Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014560535
Market Monitor Global
Oct-2021
Life Sciences
109 Pages

This report contains market size and forecasts of Follicular Lymphoma Treatment in Global, including the following market information:
Global Follicular Lymphoma Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Follicular Lymphoma Treatment market was valued at 1730.4 million in 2020 and is projected to reach US$ 2202.8 million by 2027, at a CAGR of 6.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Follicular Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Lymphoma Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, By Type, 2020 (%)
Chemotherapy
Radiotherapy
Monoclonal Antibodies
Stem Cell Transplantation

China Follicular Lymphoma Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Follicular Lymphoma Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Follicular Lymphoma Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Follicular Lymphoma Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Follicular Lymphoma Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Celldex Therapeutics, Inc.
Celltrion, Inc.
Cellular Biomedicine Group, Inc.
Coherus BioSciences, Inc.
CTI BioPharma Corp.
Curis, Inc.
Dynavax Technologies Corporation
Eisai
EpiZyme, Inc.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
Immune Design Corp.
ImmunoGen, Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Follicular Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Follicular Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Follicular Lymphoma Treatment Overall Market Size
2.1 Global Follicular Lymphoma Treatment Market Size: 2021 VS 2027
2.2 Global Follicular Lymphoma Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Follicular Lymphoma Treatment Players in Global Market
3.2 Top Global Follicular Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Follicular Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Follicular Lymphoma Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Follicular Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Follicular Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Follicular Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Follicular Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Follicular Lymphoma Treatment Market Size Markets, 2021 & 2027
4.1.2 Chemotherapy
4.1.3 Radiotherapy
4.1.4 Monoclonal Antibodies
4.1.5 Stem Cell Transplantation
4.2 By Type - Global Follicular Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Follicular Lymphoma Treatment Revenue, 2016-2021
4.2.2 By Type - Global Follicular Lymphoma Treatment Revenue, 2022-2027
4.2.3 By Type - Global Follicular Lymphoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Follicular Lymphoma Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Follicular Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Follicular Lymphoma Treatment Revenue, 2016-2021
5.2.2 By Application - Global Follicular Lymphoma Treatment Revenue, 2022-2027
5.2.3 By Application - Global Follicular Lymphoma Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Follicular Lymphoma Treatment Market Size, 2021 & 2027
6.2 By Region - Global Follicular Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Follicular Lymphoma Treatment Revenue, 2016-2021
6.2.2 By Region - Global Follicular Lymphoma Treatment Revenue, 2022-2027
6.2.3 By Region - Global Follicular Lymphoma Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Follicular Lymphoma Treatment Revenue, 2016-2027
6.3.2 US Follicular Lymphoma Treatment Market Size, 2016-2027
6.3.3 Canada Follicular Lymphoma Treatment Market Size, 2016-2027
6.3.4 Mexico Follicular Lymphoma Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Follicular Lymphoma Treatment Revenue, 2016-2027
6.4.2 Germany Follicular Lymphoma Treatment Market Size, 2016-2027
6.4.3 France Follicular Lymphoma Treatment Market Size, 2016-2027
6.4.4 U.K. Follicular Lymphoma Treatment Market Size, 2016-2027
6.4.5 Italy Follicular Lymphoma Treatment Market Size, 2016-2027
6.4.6 Russia Follicular Lymphoma Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Follicular Lymphoma Treatment Market Size, 2016-2027
6.4.8 Benelux Follicular Lymphoma Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Follicular Lymphoma Treatment Revenue, 2016-2027
6.5.2 China Follicular Lymphoma Treatment Market Size, 2016-2027
6.5.3 Japan Follicular Lymphoma Treatment Market Size, 2016-2027
6.5.4 South Korea Follicular Lymphoma Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Follicular Lymphoma Treatment Market Size, 2016-2027
6.5.6 India Follicular Lymphoma Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Follicular Lymphoma Treatment Revenue, 2016-2027
6.6.2 Brazil Follicular Lymphoma Treatment Market Size, 2016-2027
6.6.3 Argentina Follicular Lymphoma Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Follicular Lymphoma Treatment Revenue, 2016-2027
6.7.2 Turkey Follicular Lymphoma Treatment Market Size, 2016-2027
6.7.3 Israel Follicular Lymphoma Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Follicular Lymphoma Treatment Market Size, 2016-2027
6.7.5 UAE Follicular Lymphoma Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Corporate Summary
7.1.2 Boehringer Ingelheim GmbH Business Overview
7.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Major Product Offerings
7.1.4 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.1.5 Boehringer Ingelheim GmbH Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Celgene Corporation
7.3.1 Celgene Corporation Corporate Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Follicular Lymphoma Treatment Major Product Offerings
7.3.4 Celgene Corporation Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.3.5 Celgene Corporation Key News
7.4 Celldex Therapeutics, Inc.
7.4.1 Celldex Therapeutics, Inc. Corporate Summary
7.4.2 Celldex Therapeutics, Inc. Business Overview
7.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.4.4 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.4.5 Celldex Therapeutics, Inc. Key News
7.5 Celltrion, Inc.
7.5.1 Celltrion, Inc. Corporate Summary
7.5.2 Celltrion, Inc. Business Overview
7.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.5.4 Celltrion, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.5.5 Celltrion, Inc. Key News
7.6 Cellular Biomedicine Group, Inc.
7.6.1 Cellular Biomedicine Group, Inc. Corporate Summary
7.6.2 Cellular Biomedicine Group, Inc. Business Overview
7.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.6.4 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.6.5 Cellular Biomedicine Group, Inc. Key News
7.7 Coherus BioSciences, Inc.
7.7.1 Coherus BioSciences, Inc. Corporate Summary
7.7.2 Coherus BioSciences, Inc. Business Overview
7.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.4.4 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.7.5 Coherus BioSciences, Inc. Key News
7.8 CTI BioPharma Corp.
7.8.1 CTI BioPharma Corp. Corporate Summary
7.8.2 CTI BioPharma Corp. Business Overview
7.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Major Product Offerings
7.8.4 CTI BioPharma Corp. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.8.5 CTI BioPharma Corp. Key News
7.9 Curis, Inc.
7.9.1 Curis, Inc. Corporate Summary
7.9.2 Curis, Inc. Business Overview
7.9.3 Curis, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.9.4 Curis, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.9.5 Curis, Inc. Key News
7.10 Dynavax Technologies Corporation
7.10.1 Dynavax Technologies Corporation Corporate Summary
7.10.2 Dynavax Technologies Corporation Business Overview
7.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Major Product Offerings
7.10.4 Dynavax Technologies Corporation Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.10.5 Dynavax Technologies Corporation Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Business Overview
7.11.3 Eisai Follicular Lymphoma Treatment Major Product Offerings
7.11.4 Eisai Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.11.5 Eisai Key News
7.12 EpiZyme, Inc.
7.12.1 EpiZyme, Inc. Corporate Summary
7.12.2 EpiZyme, Inc. Business Overview
7.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.12.4 EpiZyme, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.12.5 EpiZyme, Inc. Key News
7.13 F. Hoffmann-La Roche Ltd.
7.13.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.13.2 F. Hoffmann-La Roche Ltd. Business Overview
7.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Major Product Offerings
7.13.4 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.13.5 F. Hoffmann-La Roche Ltd. Key News
7.14 Genentech, Inc.
7.14.1 Genentech, Inc. Corporate Summary
7.14.2 Genentech, Inc. Business Overview
7.14.3 Genentech, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.14.4 Genentech, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.14.5 Genentech, Inc. Key News
7.15 Gilead Sciences, Inc.
7.15.1 Gilead Sciences, Inc. Corporate Summary
7.15.2 Gilead Sciences, Inc. Business Overview
7.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.15.4 Gilead Sciences, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.15.5 Gilead Sciences, Inc. Key News
7.16 GlaxoSmithKline Plc
7.16.1 GlaxoSmithKline Plc Corporate Summary
7.16.2 GlaxoSmithKline Plc Business Overview
7.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Major Product Offerings
7.16.4 GlaxoSmithKline Plc Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.16.5 GlaxoSmithKline Plc Key News
7.17 Hutchison MediPharma Limited
7.17.1 Hutchison MediPharma Limited Corporate Summary
7.17.2 Hutchison MediPharma Limited Business Overview
7.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Major Product Offerings
7.17.4 Hutchison MediPharma Limited Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.17.5 Hutchison MediPharma Limited Key News
7.18 Immune Design Corp.
7.18.1 Immune Design Corp. Corporate Summary
7.18.2 Immune Design Corp. Business Overview
7.18.3 Immune Design Corp. Follicular Lymphoma Treatment Major Product Offerings
7.18.4 Immune Design Corp. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.18.5 Immune Design Corp. Key News
7.19 ImmunoGen, Inc.
7.19.1 ImmunoGen, Inc. Corporate Summary
7.19.2 ImmunoGen, Inc. Business Overview
7.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Major Product Offerings
7.19.4 ImmunoGen, Inc. Follicular Lymphoma Treatment Revenue in Global (2016-2021)
7.19.5 ImmunoGen, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Follicular Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Follicular Lymphoma Treatment Market Drivers in Global Market
Table 3. Follicular Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Follicular Lymphoma Treatment in Global Market
Table 5. Top Follicular Lymphoma Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Follicular Lymphoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Follicular Lymphoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Follicular Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Follicular Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Follicular Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Celldex Therapeutics, Inc.
Celltrion, Inc.
Cellular Biomedicine Group, Inc.
Coherus BioSciences, Inc.
CTI BioPharma Corp.
Curis, Inc.
Dynavax Technologies Corporation
Eisai
EpiZyme, Inc.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
Immune Design Corp.
ImmunoGen, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE